[Prescription differences of dementia drugs in urban and rural areas in Germany].

Jens Bohlken; Gisbert W Selke; Hendrik Bussche van den

[Prescription differences of dementia drugs in urban and rural areas in Germany].

Standard

[Prescription differences of dementia drugs in urban and rural areas in Germany]. / Bohlken, Jens; Selke, Gisbert W; Bussche van den, Hendrik.

in: PSYCHIAT PRAX, Jahrgang 38, Nr. 5, 5, 2011, S. 232-236.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Bohlken, J, Selke, GW & Bussche van den, H 2011, '[Prescription differences of dementia drugs in urban and rural areas in Germany].', PSYCHIAT PRAX, Jg. 38, Nr. 5, 5, S. 232-236. <http://www.ncbi.nlm.nih.gov/pubmed/21425036?dopt=Citation>

APA

Bohlken, J., Selke, G. W., & Bussche van den, H. (2011). [Prescription differences of dementia drugs in urban and rural areas in Germany]. PSYCHIAT PRAX, 38(5), 232-236. [5]. http://www.ncbi.nlm.nih.gov/pubmed/21425036?dopt=Citation

Vancouver

Bohlken J, Selke GW, Bussche van den H. [Prescription differences of dementia drugs in urban and rural areas in Germany]. PSYCHIAT PRAX. 2011;38(5):232-236. 5.

Bibtex

@article{5753ba4d8ec54c669d71533736bd3867,

title = "[Prescription differences of dementia drugs in urban and rural areas in Germany].",

abstract = "The objective of this study was to detect regional variability in anti-dementia drug prescriptions in metropolitan and rural regions of Germany in order to assess the widespread assumption that dementia treatment coverage is lower in rural areas because of the lower physician density in ambulatory care, especially for neuropsychiatrists.",

keywords = "Germany, Humans, Aged, Alzheimer Disease/*drug therapy/*epidemiology, Ambulatory Care/statistics & numerical data, Galantamine/therapeutic use, General Practice/manpower/statistics & numerical data, Indans/therapeutic use, Medically Underserved Area, Memantine/therapeutic use, Neuropsychiatry/manpower/statistics & numerical data, Nootropic Agents/*therapeutic use, Phenylcarbamates/therapeutic use, Physician's Practice Patterns/*statistics & numerical data, Piperidines/therapeutic use, Rural Population/*statistics & numerical data, Urban Population/*statistics & numerical data, Germany, Humans, Aged, Alzheimer Disease/*drug therapy/*epidemiology, Ambulatory Care/statistics & numerical data, Galantamine/therapeutic use, General Practice/manpower/statistics & numerical data, Indans/therapeutic use, Medically Underserved Area, Memantine/therapeutic use, Neuropsychiatry/manpower/statistics & numerical data, Nootropic Agents/*therapeutic use, Phenylcarbamates/therapeutic use, Physician's Practice Patterns/*statistics & numerical data, Piperidines/therapeutic use, Rural Population/*statistics & numerical data, Urban Population/*statistics & numerical data",

author = "Jens Bohlken and Selke, {Gisbert W} and {Bussche van den}, Hendrik",

year = "2011",

language = "Deutsch",

volume = "38",

pages = "232--236",

journal = "PSYCHIAT PRAX",

issn = "0303-4259",

publisher = "Georg Thieme Verlag KG",

number = "5",

}

RIS

TY - JOUR

T1 - [Prescription differences of dementia drugs in urban and rural areas in Germany].

AU - Bohlken, Jens

AU - Selke, Gisbert W

AU - Bussche van den, Hendrik

PY - 2011

Y1 - 2011

N2 - The objective of this study was to detect regional variability in anti-dementia drug prescriptions in metropolitan and rural regions of Germany in order to assess the widespread assumption that dementia treatment coverage is lower in rural areas because of the lower physician density in ambulatory care, especially for neuropsychiatrists.

AB - The objective of this study was to detect regional variability in anti-dementia drug prescriptions in metropolitan and rural regions of Germany in order to assess the widespread assumption that dementia treatment coverage is lower in rural areas because of the lower physician density in ambulatory care, especially for neuropsychiatrists.

KW - Germany

KW - Humans

KW - Aged

KW - Alzheimer Disease/drug therapy/epidemiology

KW - Ambulatory Care/statistics & numerical data

KW - Galantamine/therapeutic use

KW - General Practice/manpower/statistics & numerical data

KW - Indans/therapeutic use

KW - Medically Underserved Area

KW - Memantine/therapeutic use

KW - Neuropsychiatry/manpower/statistics & numerical data

KW - Nootropic Agents/therapeutic use

KW - Phenylcarbamates/therapeutic use

KW - Physician's Practice Patterns/statistics & numerical data

KW - Piperidines/therapeutic use

KW - Rural Population/statistics & numerical data

KW - Urban Population/statistics & numerical data

KW - Germany

KW - Humans

KW - Aged

KW - Alzheimer Disease/drug therapy/epidemiology

KW - Ambulatory Care/statistics & numerical data

KW - Galantamine/therapeutic use

KW - General Practice/manpower/statistics & numerical data

KW - Indans/therapeutic use

KW - Medically Underserved Area

KW - Memantine/therapeutic use

KW - Neuropsychiatry/manpower/statistics & numerical data

KW - Nootropic Agents/therapeutic use

KW - Phenylcarbamates/therapeutic use

KW - Physician's Practice Patterns/statistics & numerical data

KW - Piperidines/therapeutic use

KW - Rural Population/statistics & numerical data

KW - Urban Population/statistics & numerical data

M3 - SCORING: Zeitschriftenaufsatz

VL - 38

SP - 232

EP - 236

JO - PSYCHIAT PRAX

JF - PSYCHIAT PRAX

SN - 0303-4259

IS - 5

M1 - 5

ER -